Evopoint Biosciences Co. Ltd.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Evopoint Biosciences Co. Ltd. is publicly traded on SHH under the ticker 688837.SS.
Evopoint Biosciences Co., Ltd. operates as a biopharmaceutical company that offers therapies for patients with oncology and multidrug-resistant infections. The company's three core technology platforms are a Small Molecule Drug Discovery Platform, a Novel Antibody Discovery Platform, and a Targeted Protein Degradation Platform. Several of its pipeline products have advanced to Phase III clinical trials or the New...
Can you invest in Evopoint Biosciences Co. Ltd.?
Yes. Evopoint Biosciences Co. Ltd. trades publicly on SHH as 688837.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Evopoint Biosciences Co. Ltd.
Detailed equity research is provided by MarketSnap.